Pfizer’s first-quarter results topped expectations, and the drugmaker raised its full-year profit outlook.

Pfizer on Wednesday reported first-quarter results that topped analysts’ expectations and raised its full-year profit guidance as its cancer and heart disease treatments helped offset a slump in sales of its coronavirus products.